IDEAYA Biosciences (IDYA) Treasury Shares (2018 - 2021)
IDEAYA Biosciences' (IDYA) quarterly Treasury Shares came in at $7313.0 in Q3 2021, down 50.0% year-on-year from $14625.0 in Q3 2020, and little changed quarter-over-quarter from $7313.0 in Q2 2021.
IDEAYA Biosciences (IDYA) Treasury Shares (2018 - 2021) Analysis & Trends
IDEAYA Biosciences has disclosed Treasury Shares across 4 years of filings, most recently posting $7313.0 for Q3 2021.
- Treasury Shares for Q3 2021 came in at $7313.0, down 50.0% year-over-year; the trailing twelve-month figure through Sep 2021 was $7313.0 (down 50.0% YoY), and the FY2020 annual result was $10518.0, down 55.62% from the prior year.
- Treasury Shares came in at $7313.0 for Q3 2021 at IDEAYA Biosciences, roughly flat from $7313.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $23698.0 in Q4 2019 to a low of $2811.0 in Q1 2020.
- The 4-year median for Treasury Shares is $11200.0 (2019), against an average of $11679.7.
- Across the five-year window, Treasury Shares plunged 55.62% in 2020 and surged 160.16% in 2021, its largest moves.
- IDEAYA Biosciences' Treasury Shares stood at $17900.0 in 2018, then soared by 32.39% to $23698.0 in 2019, then slumped by 55.62% to $10518.0 in 2020, then slumped by 30.47% to $7313.0 in 2021.
- The last three Treasury Shares figures came in at $7313.0 (Q3 2021), $7313.0 (Q2 2021), and $7313.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 7,313.00 |
| Sep 30, 2021 | 7,313.00 |
| Jun 30, 2021 | 7,313.00 |
| Jun 30, 2021 | 7,313.00 |
| Mar 31, 2021 | 7,313.00 |
| Mar 31, 2021 | 7,313.00 |
| Dec 31, 2020 | 10,518.00 |
| Dec 31, 2020 | 10,518.00 |
| Sep 30, 2020 | 14,625.00 |
| Sep 30, 2020 | 14,625.00 |
| Jun 30, 2020 | 14,625.00 |
| Jun 30, 2020 | 14,625.00 |
| Mar 31, 2020 | 2,811.00 |
| Mar 31, 2020 | 2,811.00 |
| Dec 31, 2019 | 23,698.00 |
| Dec 31, 2019 | 23,698.00 |
| Sep 30, 2019 | 14,244.00 |
| Sep 30, 2019 | 14,244.00 |
| Jun 30, 2019 | 11,882.00 |
| Jun 30, 2019 | 11,882.00 |